Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Rickli

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
American Heart Journal|August 4, 2018
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary interventionSarah Hugelshofer, Marco Roffi, Fabienne Witassek, et al.
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
American Heart Journal|March 29, 2008
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and designMatthias Pfisterer, Osmund Bertel, Piero O Bonetti, et al.
Lancet (London, England)|September 1, 2022
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validationFlorian A Wenzl, Simon Kraler, Gareth Ambler, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Swiss Medical Weekly|March 22, 2014
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensusGregoire Wuerzner, Olivier Muller, Paul Erne, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2017
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionStephane Fournier, Olivier Muller, Umberto Benedetto, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
JAMA Network Open|April 13, 2026
Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical TrialDavid Nanchen, Aziz Chaouch, Renzo Scuderi, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
American Heart Journal|August 4, 2018
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary interventionSarah Hugelshofer, Marco Roffi, Fabienne Witassek, et al.
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
American Heart Journal|March 29, 2008
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and designMatthias Pfisterer, Osmund Bertel, Piero O Bonetti, et al.
Lancet (London, England)|September 1, 2022
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validationFlorian A Wenzl, Simon Kraler, Gareth Ambler, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Swiss Medical Weekly|March 22, 2014
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensusGregoire Wuerzner, Olivier Muller, Paul Erne, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 10, 2017
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionStephane Fournier, Olivier Muller, Umberto Benedetto, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
JAMA Network Open|April 13, 2026
Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical TrialDavid Nanchen, Aziz Chaouch, Renzo Scuderi, et al.
Pageof 20